Los Angeles, California (PRWEB) December 15, 2015
In response to New Scientist and Washington Post news releases, Kleritec is preparing for an increase in the demand for proper education and the need for preventative products in the fight against bacterial infection. Their newly formed Infection Prevention Team operates with the goal of preventing outbreaks before they happen. The epidemic sieges of bacterial and viral infections have dramatically escalated in currently becoming both a national and international health crisis. According to recent medical statistics from the Center for Disease Control (CDC), highly resistant staph infections, such as MRSA*, are now responsible for more deaths in the nation than from AIDS, in addition to sending hundreds of thousands of its stricken victims to hospitals for emergency care. Leading the charge in effectively combating this health crisis is the company Kleritec, a national and international distributor of highly eminent antimicrobial products that are specifically formulated to kill 99.99% of bacterial and viral infections in safeguarding against these serious and deadly diseases. Kleritec has formed an infection prevention team to educate and help with regulation and compliance. Kleritec’s infection prevention team can help organizations meet the stringent guidelines of the CDC, APIC, OSHA, and FDA criteria and, consequently, have earned the trust of countless hospitals, schools, day care providers, municipalities, and a host of other institutions.